Workflow
Cidara Therapeutics(CDTX)
icon
Search documents
Cidara Therapeutics (CDTX) Presents At Wedbush PacGrow Healthcare Conference - Slideshow
2019-08-15 19:35
| --- | --- | --- | --- | |------------------------------------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | New Hope for Serious Infections | | | | | Corporate Presentation August 2019 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | © Cidara Therapeutics 2019 Forward-Looking Statements These slides and the accompanying oral presentation contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Because such statem ...
Cidara Therapeutics(CDTX) - 2019 Q2 - Quarterly Report
2019-08-08 20:09
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, Par Value $0.0001 Per Share CDTX The Nasdaq Global Market Large accelerated filer o Accelerated filer x Non-accelerated filer o Smaller reporting company x Emerging growth company x FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2019 o TRANSITI ...
Cidara Therapeutics(CDTX) - 2019 Q1 - Quarterly Report
2019-05-09 20:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2019 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number: 001-36912 CIDARA THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) Delaware 46-1537286 (State or Other Jurisdict ...
Cidara Therapeutics(CDTX) - 2018 Q4 - Annual Report
2019-02-28 21:29
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-36912 CIDARA THERAPEUTICS, INC. (Exact name of Registrant as specified in its charter) Delaware 46-1537286 (State or Other Jurisdicti ...